コンテンツへスキップ
Merck
  • Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in children.

Correlation between circulating proteasome activity, total protein and c-reactive protein levels following burn in children.

Burns : journal of the International Society for Burn Injuries (2013-12-03)
E Matuszczak, M Tylicka, W Dębek, A Hermanowicz, H Ostrowska
要旨

To characterize burn-induced changes following burn in children by analyzing circulating proteasome (c-proteasome) activity in the plasma in correlation with total protein and c-reactive protein levels in the plasma, and the severity of the burn. Fifty consecutive children scalded by hot water who were managed at the Department of Pediatric Surgery after primarily presenting with burns in 4-20% TBSA were included into the study. The children were aged 9 months up to 14 years (mean age 2.5±1 years). Patients were divided into groups according to the pediatric injury severity score used by American Burns Association. Plasma proteasome activity was assessed using Suc-Leu-Leu-Val-Tyr-AMC peptide substrate, 2-6 h, 12-16 h, 3 days, 5 days, and 7 days after injury. 20 healthy children consecutively admitted for planned inguinal hernia repair served as controls. Statistically significant elevation of plasma c-proteasome activity was noted in all groups of burned children 12-16 h after the injury. We found a strong negative correlation of c-proteasome activity with total protein levels, and positive correlation with CRP levels 12-16 h after burn. We also found stronger correlation between c-proteasome activity and severity of burn, than CRP level and severity of burn 12-16 h, and 3 days after the burn. Correlations were statistically significant. This study characterized circulating 20S proteasome activity levels after burn. C-proteasome activity elevate after burn and correlate negatively with plasma total protein level, thus plasma 20S proteasome activity could be additional biomarker of tissue damage in burn in pediatric population.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ホスファターゼの基質, 5 mg tablets
Sigma-Aldrich
4-ニトロフェニルリン酸 二ナトリウム塩 六水和物, suitable for enzyme immunoassay, ≥99.0% (enzymatic)
Sigma-Aldrich
4-ニトロフェニルリン酸 二ナトリウム塩 六水和物, tablet
Sigma-Aldrich
4-ニトロフェニルリン酸 二ナトリウム塩 六水和物, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
ホスファターゼの基質, powder
Sigma-Aldrich
4-ニトロフェニルリン酸 二ナトリウム塩 六水和物, tablet
Sigma-Aldrich
ホスファターゼの基質, 40 mg tablets
Sigma-Aldrich
4-ニトロフェニルリン酸 二ナトリウム塩 六水和物, tablet
Sigma-Aldrich
ホスファターゼの基質, 100 mg capsules
Sigma-Aldrich
ホスファターゼの基質, 40 mg capsules
Sigma-Aldrich
ホスファターゼの基質, Suitable for manufacturing of diagnostic kits and reagents